Johnson & Johnson said on Thursday it has asked U.S. health regulators to authorize its single-dose COVID-19 vaccine for emergency use.The drugmaker’s application to the U.S.
Food and Drug Administration (FDA) follows its Jan. 29 report in which it said the vaccine had a 66 per cent rate of preventing infections in its large global trial.
Johnson & Johnson’s one-dose coronavirus shot appears less effective than others J&J’s single-shot vaccine could help boost supply and simplify the U.S.
immunization campaign, amid concerns of fresh surges due to the more contagious UK coronavirus variant and the potential of lower vaccine efficacy against the variant that first emerged in South Africa.[ Sign up for our Health IQ newsletter for the.